MediFind

Find a Doctor

Delphine Rea

Hôpital Saint Louis
Female

Bio


Delphine Rea is in Paris, France. They have been an author on 101 peer reviewed articles and participated in 2 clinical trials in the past 15 years. Dr. Rea's top three areas of expertise are Chronic Myelogenous Leukemia, Leukemia, and Philadelphia-Negative Chronic Myeloid Leukemia.

Contact

Paris, FR

Latest Research


Latest Advance
Study
  • Condition: Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
  • Journal: The New England journal of medicine
  • Treatment Used: Asciminib
  • Number of Patients: 141
  • Published —
The study researched using Asciminib to treat chronic myeloid leukemia after ABL kinase inhibitor failure.
Latest Advance
Study
  • Condition: Chronic Myeloid Leukemia (CML)
  • Journal: British journal of haematology
  • Treatment Used: Tyrosine Kinase Inhibitors (TKIs)
  • Number of Patients: 427
  • Published —
This study analyzed the pharmacovigilance declarations for the 6 months after stopping tyrosine kinase inhibitors (TKIs) in a large cohort of patients with chronic myeloid leukemia (CML) to identify factors that may predispose to tyrosine kinase inhibitor withdrawal syndrome (WS).
Latest Advance
Study
  • Condition: Chronic myelogenous leukemia
  • Journal: Experimental hematology
  • Treatment Used: Ponatinib
  • Number of Patients: 48
  • Published —
This study evaluated ponatinib in patients with chronic myelogenous leukemia who failed more than two tyrosine kinase inhibitors.
Latest Advance
Study
  • Condition: Philadelphia Chromosome-Positive Leukemia
  • Journal: Haematologica
  • Treatment Used: Dasatinib
  • Number of Patients: 2712
  • Published —
This study evaluated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib.

Clinical Trials


All Publications
View All


Contact

Paris, FR

Insurance

Contact them to find out if they accept your insurance plan.